Literature DB >> 19256776

Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix.

Geok Chin Tan1, Noor Akmal Sharifah, Mohd Sidik Shiran, Shuib Salwati, Ahmad Zailani Hatta, Hock Oon Paul-Ng.   

Abstract

The differentiation between cervical intraepithelial neoplasia 3 (CIN 3) and early squamous cell carcinoma (SCC) of the cervix may be difficult in certain situations. Identification of invasion beyond the basement membrane is the gold standard for the diagnosis of the latter. The objective of this study was to determine whether the use of Ki-67 and p53 could help in solving the above dilemma. This was a retrospective study on 61 cases of cervical neoplasms comprising of 25 cases of CIN 3 and 36 SCC. All cases were evaluated by immunohistochemistry using Ki-67 and p53 monoclonal antibodies. Results showed that the differences of Ki-67 and p53 expression between CIN 3 and SCC were statistically significant. In conclusion, Ki-67 and p53 may serve as helpful adjuncts to routinely-stained histological sections in differentiating between CIN 3 and SCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19256776

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  ROC-Analysis Derived Immunohistochemical P53 Cut-Off Scores as an Adjunct to Routine Histopathology for Better Diagnostic Compartmentalisation of Cervical Lesions.

Authors:  Ayushi Shukla; Rekha Sachan; Malti Maurya; Munna Lal Patel; Pushplata Sankhwar
Journal:  Int J Appl Basic Med Res       Date:  2022-07-26

2.  A comparative analysis of clinical and molecular factors with the stage of cervical cancer in a Brazilian cohort.

Authors:  Sergio M Amaro-Filho; Jonathan E Golub; Gerard J Nuovo; Cynthia B Cunha; José E Levi; Luisa L Villa; Cecília V Andrade; Fabio B Russomano; Aparecida Tristão; Andrea Pires; Alcina F Nicol
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.